Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs

NCT03981211 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatitis C
Liver Inflammation
Liver Cirrhoses

Interventions

DRUG: Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
DRUG: Sofosbuvir 400 MG + Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet

Sponsor

Kirby Institute